🧬Tidera Health
⚕️

Educational tool only. Does not confirm eligibility or provide medical advice. Always consult your physician before pursuing any trial.

NeurologyICD-10: G20

Find Recruiting Clinical Trials for Parkinson's Disease

Search neuroprotective, motor symptom, and disease-modifying Parkinson's trials matched to your disease stage.

🔍 Search Parkinson's Disease Trials →

About Parkinson's Disease

Parkinson's disease is a progressive neurodegenerative disorder characterized by motor symptoms (tremor, rigidity, bradykinesia, postural instability) and non-motor symptoms (cognitive changes, autonomic dysfunction, sleep disorders). The primary cause is loss of dopamine-producing neurons in the substantia nigra. Current treatments are symptomatic — levodopa, dopamine agonists, MAO-B inhibitors — with no disease-modifying therapies yet approved.

What Types of Parkinson's Disease Clinical Trials Exist?

Parkinson's clinical trials test disease-modifying therapies (alpha-synuclein targeting, GLP-1 agonists, gene therapy), advanced motor symptom management (extended-release levodopa, LCIG), non-motor symptom treatment, and biomarker studies. Disease stage (Hoehn & Yahr) and symptom duration commonly affect eligibility.

Find Recruiting Parkinson's Disease Trials Near You

Enter your profile and we'll search ClinicalTrials.gov in real time — matching trials to your age, location, and treatment history. Free, no account required.

Search Parkinson's Disease Trials →

Data from ClinicalTrials.gov · Updated in real time · Educational use only

Frequently Asked Questions

What clinical trials are available for Parkinson's disease?▾
Recruiting Parkinson's trials include disease-modifying studies (alpha-synuclein antibodies, GLP-1 agonists, gene therapies), motor management trials (extended-release carbidopa/levodopa, apomorphine devices), and observational biomarker studies.
Does my Parkinson's disease stage affect trial eligibility?▾
Yes. Many trials specify eligibility based on disease stage (Hoehn & Yahr scale), symptom duration, and whether you have motor complications like dyskinesia or off episodes. Early-stage trials often exclude patients with advanced motor fluctuations.
Are observational Parkinson's studies different from treatment trials?▾
Yes. Observational studies (like PPMI) follow patients over time to collect biomarker and clinical data — no investigational drug is provided. Treatment trials test new drugs or devices. Tidera flags observational studies so you can distinguish them.

Related Conditions

Alzheimer's DiseaseMultiple SclerosisALS

Data source: All clinical trial information is sourced from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine. Tidera Health is an independent educational platform and is not affiliated with ClinicalTrials.gov or the National Library of Medicine. Always verify trial details directly with the research coordinator or your physician.